Clinical trial Recruiting at 1 site Observational Ages 18 to 60

Effect of Periodontal Therapy on Gut Microbes and Inflammation in People with Inflammatory Bowel Disease

Official title: Effects of Periodontal Therapy on Clinical Outcomes in Patients With Inflammatory Bowel Disease: A Prospective Observational Study

Run by University of Turin, Italy · NCT07905859 · Data updated 2026-11-12

This study tests whether treating gum disease in people with inflammatory bowel disease can influence the gut microbiome and markers of systemic inflammation.

More Dysbiosis trials

Quick facts

Study typeObservational
Ages18 Years to 60 Years
SexAll
Enrollment30 (estimated)
SponsorUniversity of Turin, Italy
Academic / other
Locations1 site (Turin, Turin)
StatusRecruiting
StartedMarch 3, 2026
Main results expectedSeptember 30, 2027
Study endsDecember 23, 2027
Registry record updatedOctober 30, 2026
Trial IDNCT07905859 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with diagnosed ulcerative colitis or Crohn's disease who have moderate to severe periodontitis (Stage III/IV), BMI 20–29, a free diet, and at least 20 teeth.

Probably not a fit

Patients without periodontitis or with BMI outside 20–29, or those who recently used antibiotics/probiotics or have systemic diseases, may not experience a linked benefit in this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational prospective study conducted at CIR Dental School in Turin, led by the University of Turin. It will observe adults with ulcerative colitis or Crohn's disease who have stage III or IV periodontitis to see how conventional periodontal treatment affects their gut microbiome and systemic inflammatory parameters. The research focuses on the oral-gut axis and its potential role in chronic inflammatory conditions. No interventional arms beyond standard periodontal therapy are described, and the study aims to identify associations between periodontal health improvements and gut-related outcomes. Results may inform future trials and understanding of how oral health relates to IBD.

Why it matters

Potential benefit: If successful, findings could clarify whether improving periodontal health helps modulate gut inflammation and microbiota in IBD patients.

How similar studies have gone: While the oral-gut axis is a growing area of interest, this observational work is relatively novel in directly linking periodontal therapy to gut microbiome and systemic inflammation in IBD.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* clinical and instrumental diagnosis of ulcerative colitis or Crohn's disease
* periodontitis Stage III or IV
* BMI between 20 and 29 kg/m2
* free diet
* presence of at least 20 teeth

Exclusion Criteria:

* systemic diseases (including diabetes, thyroid, liver, or kidney diseases)
* dietary allergies
* use of antibiotics or probiotics during the previous 30 days
* pregnancy or breastfeeding

Where it's running

  • CIR Dental School
    Turin, Turin, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.